A Randomized, Double-Blind, Dose Ranging, Dose Comparison-Controlled Trial to Determine the Safety and Efficacy of BMS-298585 in Subjects With Type 2 Diabetes
A Randomized, Double-Blind, Dose Ranging, Dose Comparison-Controlled Trial to Determine the Safety and Efficacy of BMS-298585 in Subjects With Type 2 Diabetes
A Randomized, Double-Blind, Dose-Ranging, Dose Comparison-Controlled Trial to Determine the Safety and Efficacy of BMS-298585 in Subjects with Type 2 Diabetes
Inclusion Criteria:
Exclusion Criteria:
Hot Springs, Arizona, United States
Fayette, Arkansas, United States
Raleigh, California, United States
Rolling Hills Estate, California, United States
Moorehead City, North Carolina, United States
Colombus, Ohio, United States
Buenos Aires, Buenos Aires, Argentina
Fullerton, South Australia, Australia
S. J. Rio Preto, São Paulo, Brazil
Drummonville, Quebec, Canada
Ottawa, Quebec, Canada
Distrito Federal, Mexico City, Mexico
Ryswyk, Netherlands
Stalowa, Wola, Poland
George, Northern Cape, South Africa
Tygerberg, Western Cape, South Africa
Herston, Queensland, Spain
Newtonabbey, Armach, United Kingdom
Lanarkshire, Strathclyde, United Kingdom
Chelmsley Wod, West Midlands, United Kingdom